As the spectrum of therapeutic options broadens, the possibility of an early and accurate
diagnosis of Alzheimer's disease (AD), or even isolation of a group at high risk of …

Epidemiological and molecular studies suggest that Alzheimer's disease (AD) has multiple
etiologies including genetic mutations, genetic variations affecting susceptibility and …

Alzheimer's Disease (AD) is one of the most common form of dementia occurring in elderly
population worldwide. Currently Aβ42, tau and p-tau in the cerebrospinal fluid is estimated …

With the development of new therapeutic strategies, and the concept of mild cognitive
impairment (MCI) as an early stage of Alzheimer's disease (AD), there is an increasing need …

A growing body of evidence suggests that Alzheimer's disease (AD) is a multifactorial
disease resulting in the well-known, common neuropathological pathway characterized by …

Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

A heterogeneous and slowly progressive disease with extracellular amyloid-β (Aβ) deposits
and intracellular hyperphosphorylated tau protein aggregates, Alzheimer's disease (AD) is …

Biomarkers for Alzheimer's disease have many diagnostic and therapeutic uses. They can
be used to facilitate diagnosis, particularly early diagnosis and possibly presymptomatic …

Traditionally Alzheimer's disease (AD) has been diagnosed and its course followed based
on clinical observations and cognitive testing, and confirmed postmortem by demonstrating …

The diagnosis of Alzheimer's disease (AD) is mainly performed by excluding other disorders
with similar clinical features. In addition, an analysis of symptoms and signs, blood studies …